Roadzen Reports Record Q4 Revenue, Narrows Losses by 69%, Targets FY27 Profitability & $100M Run-Rate
RDZN sits 69% above its 52-week low of $0.811.
Summary
Roadzen Inc. announced record Q4 FY2026 revenue, a 69% reduction in full-year net loss, and a path to Adjusted EBITDA profitability and $100 million annualized revenue for FY2027, directly addressing prior financial concerns.
Key Events · Earnings and Guidance · RDZN
-
Record Revenue Growth
Roadzen reported record Q4 FY2026 revenue of $16.1 million, up 42% year-over-year, and full-year revenue of $55.0 million, up 24% from FY2025.
-
Significant Loss Reduction
Full-year net loss attributable to ordinary shareholders narrowed by 69% to $(22.5) million, and Adjusted EBITDA loss improved by 58% to $(3.5) million, with Q4 Adjusted EBITDA loss nearing breakeven at $(0.4) million.
-
Strong FY2027 Outlook
The company projects a clear path to positive Adjusted EBITDA and a $100 million annualized revenue run-rate for the coming fiscal year, exiting FY2026 at a $64 million run-rate.
-
Balance Sheet Strengthening
Roadzen reduced short-term borrowings by 60% to $7.8 million and extended its $11.5 million senior secured facility with Mizuho to July 2027, improving near-term liquidity.
Analysis · RDZN · Finance
This 8-K furnishes the company's Q4 and full-year FY2026 financial results, which are highly significant as they directly address the 'going concern' warning disclosed in the 10-K filed on the same day. The report details record revenue growth, substantial reductions in net and Adjusted EBITDA losses, and provides a clear path to profitability and a $100 million annualized revenue run-rate for FY2027. These positive operational and financial trends, coupled with balance sheet improvements and significant new business commitments, offer a strong counter-narrative to the previous liquidity concerns, indicating a potential turnaround.
At the time of this filing, RDZN was trading at $1.37 on NASDAQ in the Finance sector, with a market capitalization of approximately $115.9M. The 52-week trading range was $0.81 to $2.56. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.